Millipore Sigma Vibrant Logo

420129 JNK Inhibitor V - CAS 345987-15-7 - Calbiochem

The JNK Inhibitor V, also referenced under CAS 345987-15-7, controls the biological activity of JNK. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: SAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245

Primary Target: hJNK 1, hJNK 2, hJNK 3
View Products on Sigmaaldrich.com
420129
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
345987-15-7C₂₀H₁₆N₆S

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
420129-5MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration.
      Catalogue Number420129
      Brand Family Calbiochem®
      SynonymsSAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245
      References
      ReferencesGaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
      Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
      Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
      Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.
      Product Information
      CAS number345987-15-7
      ATP CompetitiveY
      FormYellow solid
      Hill FormulaC₂₀H₁₆N₆S
      Chemical formulaC₂₀H₁₆N₆S
      Hygroscopic Hygroscopic
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Application CommentsSoluble in DMSO, aliquot & store at -20*C; stable for 3 months
      Biological Information
      Primary TargethJNK 1, hJNK 2, hJNK 3
      Primary Target IC<sub>50</sub>150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively
      Purity≥95% by HPLC (sum of two isomers)
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      420129-5MG 04055977188073

      Documentation

      JNK Inhibitor V - CAS 345987-15-7 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      JNK Inhibitor V - CAS 345987-15-7 - Calbiochem Analysenzertifikate

      TitelChargennummer
      420129

      Literatur

      Übersicht
      Gaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
      Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
      Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
      Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision04-January-2010 RFH
      SynonymsSAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245
      DescriptionA cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration.
      FormYellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number345987-15-7
      Chemical formulaC₂₀H₁₆N₆S
      Structure formulaStructure formula
      Purity≥95% by HPLC (sum of two isomers)
      SolubilityDMSO (10 mg/ml)
      CommentsSoluble in DMSO, aliquot & store at -20*C; stable for 3 months
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      ReferencesGaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
      Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
      Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
      Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.